We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca, Oxford Fortifying COVID-19 Vaccine Against Viral Variants
AstraZeneca, Oxford Fortifying COVID-19 Vaccine Against Viral Variants
AstraZeneca and the University of Oxford said they are working “as rapidly as possible” to tailor their COVID-19 vaccine for significant new coronavirus mutations and believe the revamped vaccine will be ready in the fall — and that their existing vaccine has been shown to reduce transmission of disease.